Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference News provided by Share this article Share this article IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance today during its annual investor conference. Highlights Presenting long-term strategic initiatives and growth outlook Projecting 2021 global sales of $4.9-5.3 billion; underlying growth in the mid-teens Projecting 2021 TAVR sales of $3.2-...
Source: prnewswire.com